Infection may no longer be a nearly certain death sentence, but HIV continues to spread globally, most notably in Asia and Africa. After plateauing in the early part of the 2000s, the number of people living with HIV has been rising again, reaching 36.7 million in 2015.
That trend underscores the importance of making HIV drugs more easily available in poorer countries, and two of the companies on the 2016 Fortune Change the World list have been at the forefront of that effort. Thanks to licensing efforts in under-resourced countries, Gilead Sciences (#4 on the list) (GILD) is on the cusp of treating 10 million people with its HIV drugs. And Cipla (#46), the Indian pharmaceutical giant, says its anti-AIDS drugs now reach patients in 115 countries.
Click here to see all the companies on the new Fortune Change the World list.
For more on Change the World list, watch this video:
This chart appears as part of the “Change the World” package in the September 1, 2016 issue of Fortune.
